-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.39 million

PUBT·05/18/2026 22:18:50
Listen to the news
United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.39 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares on May 15, 2026 at USD 146.03.
  • Rothblatt sold 9,500 shares the same day in a series of trades at weighted-average prices ranging from USD 566.19 to USD 572.25.
  • Directly held shares fell to 40,513 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000055), on May 18, 2026, and is solely responsible for the information contained therein.